HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jie-Yu Liu Selected Research

Zeranol

5/2011Zeranol induces cell proliferation and protein disulfide isomerase expression in mammary gland of ACI rat.
2/2011Serum derived from zeranol-implanted ACI rats promotes the growth of human breast cancer cells in vitro.
1/2011Zeranol may increase the risk of leptin-induced neoplasia in human breast.
1/2011Zeranol down-regulates p53 expression in primary cultured human breast cancer epithelial cells through epigenetic modification.
12/2010Aromatase expression in leptin-pretreated human breast pre-adipocytes is enhanced by zeranol and suppressed by (-)-gossypol.
11/2010Serum harvested from heifers one month post-zeranol implantation stimulates MCF-7 breast cancer cell growth.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jie-Yu Liu Research Topics

Disease

9Breast Neoplasms (Breast Cancer)
03/2013 - 11/2010
8Neoplasms (Cancer)
02/2022 - 01/2011
4Carcinogenesis
01/2019 - 04/2011
1Hematologic Neoplasms (Hematological Malignancy)
01/2022
1Muscular Diseases (Myopathy)
01/2022
1Retinitis Pigmentosa (Pigmentary Retinopathy)
01/2022
1Metabolic Syndrome (Dysmetabolic Syndrome X)
12/2021
1Diabetes Mellitus
12/2021
1Muscular Dystrophies (Muscular Dystrophy)
01/2021
1Body Weight (Weight, Body)
08/2020
1Inflammation (Inflammations)
12/2019
1Stomach Neoplasms (Stomach Cancer)
01/2019
1Lymphoma (Lymphomas)
01/2016
1Melanoma (Melanoma, Malignant)
01/2016
1B-Cell Lymphoma (Lymphoma, B Cell)
01/2016
1Endometrioid Carcinoma
11/2015
1Adenomatous Polyposis Coli (Familial Adenomatous Polyposis)
11/2015
1Colonic Neoplasms (Colon Cancer)
11/2015
1Obesity
12/2010

Drug/Important Bio-Agent (IBA)

6ZeranolIBA
05/2011 - 11/2010
4Estrogens (Estrogen)FDA Link
04/2011 - 11/2010
3Messenger RNA (mRNA)IBA
12/2019 - 05/2011
2Biomarkers (Surrogate Marker)IBA
01/2019 - 05/2011
2GossypolIBA
03/2013 - 11/2010
2LeptinIBA
01/2011 - 11/2010
1CarbonIBA
02/2022
1Janus KinasesIBA
02/2022
1IsothiuroniumIBA
02/2022
1STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA
02/2022
1Pharmaceutical PreparationsIBA
01/2022
1Checkpoint Kinase 1IBA
01/2022
1retinol dehydrogenaseIBA
01/2022
1HDL CholesterolIBA
12/2021
1TeaIBA
12/2021
1Dystroglycans (Dystroglycan)IBA
01/2021
1Blood Glucose (Blood Sugar)IBA
08/2020
1GalactosidasesIBA
12/2019
1Growth Differentiation Factor 15IBA
01/2019
1RNA (Ribonucleic Acid)IBA
01/2019
1Apoptosis Regulatory ProteinsIBA
01/2016
1Histone MethyltransferasesIBA
01/2016
1ChromatinIBA
01/2016
1Histones (Histone)IBA
01/2016
1Lysine (L-Lysine)FDA Link
01/2016
1Oncogene Proteins (Oncogene Protein)IBA
01/2016
1Tumor Suppressor Protein p53IBA
01/2016
1CateninsIBA
11/2015
1TubulinIBA
07/2014
1Endocrine DisruptorsIBA
04/2011
1Aromatase (CYP19)IBA
12/2010
1Cottonseed Oil (Cottonseed)IBA
11/2010
1AdipokinesIBA
11/2010

Therapy/Procedure

1Therapeutics
02/2022
1Drug Therapy (Chemotherapy)
01/2022